Want to see ORGO full AI Analyst Report?
Organogenesis Holdings (ORGO) Income Statement
Organogenesis Holdings Income Statement
Last quarter (Q2 2026), Organogenesis Holdings's total revenue was $43.76M, a decrease of 56.58% from the same quarter last year. In Q2, Organogenesis Holdings's net income was $-99.34M. See Organogenesis Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 563.03M | $ 482.04M | $ 433.14M | $ 450.89M | $ 467.36M | |
| $ 425.51M | $ 366.30M | $ 326.66M | $ 345.87M | $ 353.16M | |
| $ 369.64M | $ 367.58M | $ 314.13M | $ 323.57M | $ 280.94M | |
| Depreciation and Amortization | $ 26.94M | $ 17.03M | $ 23.45M | $ 18.03M | $ 16.68M |
| $ 73.91M | $ 15.76M | $ 36.03M | $ 40.32M | $ 87.00M | |
| $ 55.87M | $ -1.28M | $ 12.53M | $ 22.30M | $ 72.22M | |
| $ -8.90M | $ -1.52M | $ -2.13M | $ -2.02M | $ -9.13M | |
| $ 46.97M | $ -2.81M | $ 10.39M | $ 20.28M | $ 63.09M | |
| $ 37.03M | $ 861.00K | $ 4.95M | $ 15.53M | $ 94.20M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.16 | $ -0.01 | $ 0.04 | $ 0.12 | $ 0.73 |
| Diluted EPS | $ 0.15 | $ -0.01 | $ 0.04 | $ 0.12 | $ 0.70 |
| Weighted Average Shares Outstanding | 126.74M | 131.67M | 131.23M | 130.07M | 128.33M |
| Weighted Average Shares Outstanding (Diluted) | 130.25M | 131.67M | 132.75M | 132.38M | 133.66M |
Currency in USD
